A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)-Reference-Cited by-同舟云学术

A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)

Published:2022-10 Issue:44 Volume:40 Page:6315-6325
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Banniettis Natalie,Wysocki Jacek,Szenborn Leszek,Phongsamart Wanatpreeya,Pitisuttithum Punnee,Rämet Mika,Richmond Peter,Shi Yaru,Dagan Ron,Good Lori,Papa Melanie,Lupinacci Robert,McFetridge Richard,Tamms Gretchen,Churchill Clay,Musey Luwy,Bickham Kara

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference41 articles.

1. Centers for Disease Control and Prevention. Pneumococcal disease - Types of infection. 2020. [accessed 7 April 2022].

2. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines;Tan;Clin Microbiol Rev,2012

3. Osteoarticular infections caused by Streptococcus pneumoniae in children in the post-pneumococcal conjugate vaccine era;Olarte;Pediatr Infect Dis J,2017

4. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper – February 2019;World Health Organization;Wkly Epidemiol Rec,2019

5. G. B. D. Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 2018;18(11):1191-210.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis;Health Technology Assessment;2024-07

2. Analysis of Adverse Events Post-13-Valent Pneumococcal Vaccination among Children in Hangzhou, China;Vaccines;2024-05-25

3. Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6–8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study;Vaccine;2024-05

4. Pneumokokkenimpfung im Säuglings- und im Kleinkindalter;Monatsschrift Kinderheilkunde;2024-03-11

5. Immunogenicity and Safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14^TM) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study;2023-12-24